Pathogenics, Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

Quarterly report for small businesses

Quarterly report for small businesses

Quarterly report for small businesses

Annual report for small businesses

Quarterly report for small businesses

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Prospectus supplement

Registration of securities – amended

Registration of securities – amended

Ownership

No filings in this category.

News Filter

Opko Health and Pathogenics Announce Data Publication Demonstrating the Potential Utility of Nct in a Severe Eye Infection

Change in Certifying Accountant, Financial Statements or Exhibits

Termination of Material Definitive Agreement, Financial Statements or Exhibits

Amended and Restated Agreement and Plan of Merger

Acuity Pharmaceuticals and Pathogenics Announce Preclinical Data Demonstrating Utility of Nct in Viral Conjunctivitis

Proxies

No filings in this category.

Other Filter

Correspondence with the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC

Correspondence with the SEC